[HTML][HTML] Management of venous thromboembolisms: part II. The consensus for pulmonary embolism and updates
KL Wang, YT Kao, WT Chang, HY Chang… - Acta Cardiologica …, 2020 - ncbi.nlm.nih.gov
Pulmonary embolism (PE) is a potential life-threatening condition and risk-adapted
diagnostic and therapeutic management conveys a favorable outcome. For patients at high …
diagnostic and therapeutic management conveys a favorable outcome. For patients at high …
[HTML][HTML] Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
S Odajima, T Seki, S Kato, K Tomita… - Journal of …, 2022 - ncbi.nlm.nih.gov
Objective Direct oral anticoagulants (DOACs) are increasingly being used for the treatment
of cancer-associated venous thromboembolism (CAT). However, there is limited evidence of …
of cancer-associated venous thromboembolism (CAT). However, there is limited evidence of …
The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review
L Al-Tourah, S Mithoowani, W Lim… - Journal of Thrombosis and …, 2024 - Springer
Abstract Background Direct oral anticoagulants (DOACs) are the mainstay of treatment for
venous thromboembolism (VTE) and non-valvular atrial fibrillation (AF), with or without an …
venous thromboembolism (VTE) and non-valvular atrial fibrillation (AF), with or without an …
Direct oral anticoagulants for the prevention and acute treatment of cancer-associated thrombosis
LM Attard, A Gatt, L Bertoletti, A Delluc… - Vascular Health and …, 2022 - Taylor & Francis
Cancer is a major risk factor for venous thromboembolism (VTE), and cancer-associated
thrombosis (CAT) constitutes approximately 15–25% of all VTE cases. For decades, the …
thrombosis (CAT) constitutes approximately 15–25% of all VTE cases. For decades, the …
Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies
M Sorigue, E Cañamero, P Siguenza… - Leukemia & …, 2020 - Taylor & Francis
Venous thromboembolism (VTE) is a common complication of cancer. Its treatment is
challenging because of the high risk for both VTE recurrence and bleeding. Evidence is …
challenging because of the high risk for both VTE recurrence and bleeding. Evidence is …
Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk
Aim: Treatment effects among anticoagulant-treated patients with venous thromboembolism
(VTE) and cancer across tumor types were evaluated. Methods: Patients initiating an …
(VTE) and cancer across tumor types were evaluated. Methods: Patients initiating an …
[HTML][HTML] Venous thromboembolism in cancer patients on simultaneous and palliative care
S Riondino, P Ferroni, G Del Monte, V Formica… - Cancers, 2020 - mdpi.com
Simultaneous care represents the ideal integration between early supportive and palliative
care in cancer patients under active antineoplastic treatment. Cancer patients require a …
care in cancer patients under active antineoplastic treatment. Cancer patients require a …
Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer
L Bertoletti, L Lafaie, T LeConte… - Expert Review of …, 2024 - Taylor & Francis
Cancer is known to be a powerful risk factor for Venous Thromboembolism (VTE), but this
risk varies depending on the primary cancer site (1). For example, the relative risk for VTE …
risk varies depending on the primary cancer site (1). For example, the relative risk for VTE …
Venous Thromboembolism In Cancer Patients:“From Evidence to Care”
M Salgado, E Brozos-Vázquez… - Clinical and Applied …, 2022 - journals.sagepub.com
This article seeks to review the current status of treatment and prevention of venous
thromboembolic disease (VTE) in cancer patients after the addition of direct oral …
thromboembolic disease (VTE) in cancer patients after the addition of direct oral …
An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis
B Cosmi - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction: Cancer-associated thrombosis (CAT) refers to the most common
thromboembolic complication of cancer which is venous thromboembolism (VTE). CAT …
thromboembolic complication of cancer which is venous thromboembolism (VTE). CAT …